Subcellular expression pattern and clinical significance of CBX2 and CBX7 in breast cancer subtypes
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Subcellular expression pattern and clinical significance of CBX2 and CBX7 in breast cancer subtypes
Authors
Keywords
-
Journal
Medical Molecular Morphology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-08-09
DOI
10.1007/s00795-023-00368-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Epigenetic Regulatory Protein CBX2 Promotes mTORC1 Signalling and Inhibits DREAM Complex Activity to Drive Breast Cancer Cell Growth
- (2022) Lucie J. Bilton et al. Cancers
- Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer
- (2021) Mohammad Askandar Iqbal et al. Molecular Oncology
- CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10–ERK signaling
- (2021) Zhengnan Huang et al. Cell Death & Disease
- QNBC Is Associated with High Genomic Instability Characterized by Copy Number Alterations and miRNA Deregulation
- (2021) Shristi Bhattarai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CBX7 is Dualistic in Cancer Progression Based on its Function and Molecular Interactions
- (2021) Jun Li et al. Frontiers in Genetics
- Prognostic and immune infiltrates for the Chromobox (CBX) protein family in human pancreatic adenocarcinoma
- (2021) Qian Li et al. Journal of Gastrointestinal Oncology
- Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights
- (2020) Aristomenis Anestis et al. MOLECULES
- Mammalian CBX7 isoforms p36 and p22 exhibit differential responses to serum, varying functions for proliferation, and distinct subcellular localization
- (2020) Kyu-Won Cho et al. Scientific Reports
- Co-Expression of Androgen Receptor and Cathepsin D Defines a Triple-Negative Breast Cancer Subgroup with Poorer Overall Survival
- (2020) Hanane Mansouri et al. Cancers
- Bioinformatic analysis of the expression and prognostic value of chromobox family proteins in human breast cancer
- (2020) Xiaomin Li et al. Scientific Reports
- Comprehensive Analysis of Prognostic Value and Immune Infiltration of Chromobox Family Members in Colorectal Cancer
- (2020) Qingshang Li et al. Frontiers in Oncology
- The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome
- (2018) Carmela Ricciardelli et al. CLINICAL CANCER RESEARCH
- Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer
- (2018) Tiffany A. Traina et al. JOURNAL OF CLINICAL ONCOLOGY
- The prognostic value of androgen receptors in breast cancer subtypes
- (2018) Maria Ryssdal Kraby et al. BREAST CANCER RESEARCH AND TREATMENT
- Androgen receptor expression inversely correlates with immune cell infiltration in human epidermal growth factor receptor 2–positive breast cancer
- (2018) Johan M. van Rooijen et al. EUROPEAN JOURNAL OF CANCER
- Prognostic values of distinct CBX family members in breast cancer
- (2017) Yuan-Ke Liang et al. Oncotarget
- The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data
- (2016) Ivana Bozovic-Spasojevic et al. CLINICAL CANCER RESEARCH
- Chromobox homolog 2 protein: A novel biomarker for predicting prognosis and Taxol sensitivity in patients with breast cancer
- (2016) Wang Yang Chen et al. Oncology Letters
- A Targetable Androgen Receptor–Positive Breast Cancer Subtype Hidden Among the Triple-Negative Cancers
- (2015) Damoun Safarpour et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Targeting the androgen receptor in prostate and breast cancer: several new agents in development
- (2015) T. Proverbs-Singh et al. ENDOCRINE-RELATED CANCER
- CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt/β-catenin pathway
- (2015) Hey-Yon Kim et al. FASEB JOURNAL
- Influence of Androgen Receptor Expression on the Survival Outcomes in Breast Cancer: A Meta-Analysis
- (2015) Yoonseok Kim et al. Journal of Breast Cancer
- Androgen Receptor Status Is a Prognostic Marker in Non-Basal Triple Negative Breast Cancers and Determines Novel Therapeutic Options
- (2014) Pierluigi Gasparini et al. PLoS One
- Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
- (2014) Mirco Pistelli et al. Cancers
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients
- (2010) Pierlorenzo Pallante et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started